GCTK
Glucotrack, Inc.Price
Daily candles with volume.
Signal stack
Where each data set points today.
- InstitutionsMIXED
Q2 2026: 2 added (0 new), 1 trimmed or exited.
- Short sellersBUILDING
Short interest +26.4% to 122.1K shares. 1.0 days to cover, ≈14.4% of shares.
Who's buying
13F· Q2 2026| Fund | Move | Value |
|---|---|---|
| HRT FINANCIAL LP | DOUBLED | $65.0K |
| GEODE CAPITAL MANAGEMENT, LLC | TRIM | $10.9K |
| UBS Group AG | DOUBLED | $4.3K |
| UBS Group AG | DOUBLED | $456.00 |
| OSAIC HOLDINGS, INC. | DOUBLED | $1.00 |
| UBS Group AG | DOUBLED | $461.00 |
| BANK OF AMERICA CORP /DE/ | DOUBLED | $108.00 |
| MORGAN STANLEY | NEAR_EXIT | $4.00 |
Quarterly 13F filings are due 45 days after each quarter ends.
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | — | — | — | $0.00 |
| Next Q | — | — | — | $0.00 |
| Current FY | — | — | — | $0.00 |
| Next FY | — | — | — | $0.00 |
Short side
FINRA· Sep 30, 2026| Oct 23, 2026 | Resumption Scheduled | Resumed |
| Sep 11, 2026 | Volatility Pause | Resumed |
| Aug 28, 2026 | Resumption Scheduled | Resumed |
| Jul 30, 2026 | Volatility Pause | Resumed |
SecBot reports
23 filings · 5 press releases · 1 bullish · 14 bearish · 2 mixed · 6 neutral- BEARISH 8-KOct 22, 2026
Glucotrack entered into a securities purchase agreement to issue a senior secured convertible…
Monitor the stock price relative to conversion price and floor price; if stockholder approval is not obtained, conversion could trigger massive dilution. The mandatory repayment from future…
- MIXED 8-KOct 19, 2026
Glucotrack entered into a waiver agreement with holders of existing warrants from a July 2026…
The waiver removes restrictions that would have blocked Glucotrack from issuing additional equity through variable-rate or other financings for up to 90 days, effectively reopening the door for…
- BEARISH S-1/AOct 13, 2026
Glucotrack filed Amendment No. 1 to its S-1 registration statement, registering up to 43,223,705…
The registration of 43.2M shares (18x current float) creates extreme near-term selling pressure. Monitor whether the company draws on the $50M ELOC facility, which would accelerate dilution. The…
- NEUTRAL 425Oct 13, 2026
Glucotrack filed Amendment No. 2 to its 8-K reporting the July 14, 2026 merger with Lokahi…
This filing contains no new operational data — it is a mechanical restatement for the reverse split. Monitor the company's next operational update for progress on Lokahi's LT-100 program and…
All GCTK filing & press-release reports (28)
- 8-K reportOct 22, 2026
- 8-K reportOct 19, 2026
- S-1/A reportOct 13, 2026
- 425 reportOct 13, 2026
- 8-K reportSep 28, 2026
- 424B5 reportSep 24, 2026
- 8-K reportSep 24, 2026
- 425 reportSep 23, 2026
- 8-K reportSep 23, 2026
- 8-K reportSep 18, 2026
- S-1 reportSep 17, 2026
- 8-K reportSep 14, 2026
- 8-K reportSep 9, 2026
- 8-K reportAug 27, 2026
- 8-K reportAug 10, 2026
- 8-K reportAug 5, 2026
- 8-K reportJul 30, 2026
- PRESS-RELEASE reportJul 17, 2026
- PRESS-RELEASE reportJul 16, 2026
- 425 reportJul 15, 2026
- 8-K reportMay 15, 2026
- 8-K reportMay 14, 2026
- PRESS-RELEASE reportMay 7, 2026
- 8-K reportApr 30, 2026
- 8-K reportMar 30, 2026
- 8-K reportApr 14, 2026
- PRESS-RELEASE reportMar 30, 2026
- PRESS-RELEASE reportMar 27, 2026